Quality of Life for Patients with Favorable Risk HPV-Associated Oropharyngeal Cancer After De-Intensified Chemoradiotherapy

We examined quality of life data from two prospective phase 2 studies of de-intensified chemoradiotherapy in patients with HPV-associated oropharyngeal cancer. Overall results were favorable, and most quality of life domains and symptoms returned to baseline by 3 to 6 months. Xerostomia and dysphagia continued to improve beyond 1 year post-treatment.

Source: International Journal of Radiation Oncology * Biology * Physics - November 2, 2018 Category: Radiology Authors: Kevin A. Pearlstein, Kyle Wang, Robert J. Amdur, Colette J. Shen, Roi Dagan, Jared Weiss, Juneko E. Grilley-Olson, Adam Zanation, Trevor G. Hackman, Brian Thorp, Jeffrey M. Blumberg, Samip Patel, Nathan Sheets, Mark C. Weissler, William M. Mendenhall, Bhi Source Type: research